TrialPloS one2019

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.

Alessandra Trojani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.